http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003520813-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2001-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003520813-A
titleOfInvention Ocular antiallergic compositions suitable for use in contact lenses
abstract (57) [Summary]nTopically administrable anti-allergic compositions comprising olopatadine and a polymeric quaternary ammonium preservative are suitable for use by patients wearing contact lenses. A multidose antiallergic composition suitable for use by a patient wearing a contact lens, which can be administered topically, wherein the antiallergic effective amount of a drug selected from the group consisting of olopatadine and emedastine; and as a preservative A composition comprising an ophthalmically acceptable polymeric quaternary ammonium compound, with the proviso that the composition does not comprise benzalkonium chloride.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014515355-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016169237-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101821518-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015509933-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013535451-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9533053-B2
priorityDate 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6310784-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06172179-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11292793-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9951273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001501605-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08175974-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H049339-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9932158-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9811875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001526090-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62153217-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21893738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46878555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426421

Total number of triples: 56.